Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome?

Chen Ronald C.

首页> 外文期刊>European urology >Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome?

【24h】

Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome?

机译：关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2016年第2期|共2页
作者
Chen Ronald C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy [J] . Voog Justin C., Paulus Rebecca, Efstathiou Jason A. European urology . 2016,第2期

机译：作者的回复：Ronald C. Chen。关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？ Eur Urol 2016; 69：211-2接受或不接受短期雄激素剥夺疗法的放射治疗的中危险前列腺癌患者的有利和不利结果
2. Comparative Risk-Adjusted Mortality Outcomes After Primary Surgery, Radiotherapy, or Androgen-Deprivation Therapy for Localized Prostate Cancer [J] . Michael Froehner Cancer: A Journal of the American Cancer Society . 2011,第11期

机译：局部前列腺癌的初次手术，放疗或雄激素剥夺治疗后风险比较的死亡率调整后结果
3. Reply to Comparative Risk-Adjusted Mortality Outcomes After Primary Surgery, Radiotherapy, or Androgen-Deprivation Therapy for Localized Prostate Cancer [J] . Anonymous Cancer: A Journal of the American Cancer Society . 2011,第11期

机译：答复针对局部前列腺癌的初次手术，放疗或雄激素剥夺疗法后的风险调整后死亡率比较结果
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation? [O] . Akram Saad, Jeffrey Goldstein, Yaacov R. Lawrence, 2017

机译：对高危和高危前列腺癌进行分类：它与适形放疗和雄激素剥夺的结果相关吗？
7. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer [O] . Madlung, Axel, Simcock, Mathew, Ghadjar, Pirus 2011

机译：局部前列腺癌的原发手术，放疗或雄激素剥夺治疗后经过风险调整的死亡率比较结果

Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome?

著录项

相似文献

相关主题

期刊订阅